Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Supriya Lifescience will conduct a virtual investor conference on June 12, 2026, with Choice Institutional Equities. The investor presentation for this meeting has been uploaded to the stock exchanges and the company's website.
Jun 09 2026 17:40:31
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Supriya Lifescience reported strong Q4 FY26 financial results, with revenue increasing by 50.2% to Rs.276.53 crore and net profit growing by 47.4% to Rs.74.23 crore. For the full fiscal year, revenue rose 18.9% to Rs.827.87 crore.
May 28 2026 09:14:35
Supriya Lifescience Ltd - 543434 - Corporate Action-Board to consider Dividend
Supriya Lifescience board recommended a final dividend of ₹1.00 per share for FY26, representing 50% on the face value of ₹2. This dividend is subject to shareholder approval at the upcoming AGM.
May 27 2026 18:56:09
Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting
Supriya Lifescience reported robust Q4 FY26 results with revenue up 50.2% YoY to ₹276.53 crores and net profit up 47.3% YoY to ₹74.23 crores. The full-year FY26 revenue reached ₹827.88 crores and net profit ₹209.12 crores, alongside a recommended final dividend of ₹1.00 per share.
May 27 2026 18:33:11
Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2026 And Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial Year Ended March 31, 2026.
Supriya Lifescience Board will convene on May 27, 2026, to consider and approve its audited financial results for the quarter and financial year ended March 31, 2026. The board will also recommend a dividend, if any, for the financial year 2026.
May 20 2026 16:59:26
Read More